Soumit Roy analyst JONESTRADING

Currently out of the existing stock ratings of Soumit Roy, 15 are a BUY (68.18%), 7 are a HOLD (31.82%).

Soumit Roy

Work Performance Price Targets & Ratings Chart

Analyst Soumit Roy works at JONESTRADING with a stock forecast success ratio of 20.37% fulfilled within 42.89 days on average.

Soumit Roy’s has documented 37 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DCPH, Deciphera Pharmaceuticals LLC at 29-Apr-2024.

Wall Street Analyst Soumit Roy

Analyst best performing recommendations are on AVEO (AVEO PHARMACEUTICALS).
The best stock recommendation documented was for AVEO (AVEO PHARMACEUTICALS) at 3/14/2022. The price target of $12 was fulfilled within 218 days with a profit of $7.41 (161.44%) receiving and performance score of 7.41.

Average potential price target upside

DCPH Deciphera Pharmaceuticals LLC INFI Infinity Pharmaceuticals AVEO AVEO Pharmaceuticals SAVA Cassava Sciences SBTX Silverback Therapeutics  IKT Inhibikase Therapeutics  RAIN Rain Therapeutics TCON TRACON Pharmaceuticals MRTX Mirati Ther

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

26

$0.54 (2.12%)

9

19 days ago

3/10 (30%)

$0.73 (2.89%)

235

Buy

23

19 days ago

4/6 (66.67%)

$8.58 (59.50%)

353

Buy

25.6

$0.14 (0.55%)

20 days ago

0/3 (0%)

$10.95 (74.74%)

Hold

14

$-11.46 (-45.01%)

52

5 months 29 days ago

4/4 (100%)

$1.66 (13.45%)

92

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Soumit Roy is most bullish on?

Potential upside of $0.14 has been obtained for DCPH (DECIPHERA PHARMACEUTICALS LLC)

What Year was the first public recommendation made by Soumit Roy?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?